Oxoglutarate dehydrogenase complex (OGDC)

The Oxoglutarate dehydrogenase complex (OGDC) is a key rate-limiting multienzyme assembly located in the mitochondrial matrix [1]. It catalyzes the oxidative decarboxylation of alpha-ketoglutarate to succinyl-CoA, a critical step in the tricarboxylic acid (TCA) cycle [1][2]. This reaction generates NADH, which is essential for the electron transport chain and ATP production [1]. The complex consists of three subunits: oxoglutarate dehydrogenase (E1), dihydrolipoyl transsuccinylase (E2), and dihydrolipoyl dehydrogenase (E3) [2][3]. OGDC activity is highly regulated by the energy state of the cell, including the NADH/NAD+ ratio and calcium levels [1]. Reduced activity of this complex is a hallmark of several neurodegenerative disorders, including Alzheimer's and Parkinson's diseases [4]. In cancer therapy, OGDC is targeted by drugs like devimistat to exploit the metabolic vulnerabilities of tumor cells [5]. Inhibition of the complex leads to a disruption of mitochondrial respiration and can induce cell death in metabolically active tissues [5]. Because it sits at a metabolic crossroads, it also plays a role in regulating glutamate levels and nitrogen balance [2]. Overall, OGDC is a vital metabolic hub and a promising target for treating diseases characterized by metabolic dysfunction [4][5].

Other names

Alpha-ketoglutarate dehydrogenase complex2-oxoglutarate dehydrogenase complexKGDHCOGDHC

Inhibition of the E2 subunit (dihydrolipoyl transsuccinylase) or E1 subunit (oxoglutarate dehydrogenase) to disrupt the TCA cycle and mitochondrial ATP production.